2021 Forecast Includes Rise In FDA Enforcement Actions
Source : Medtech Insight
Continuing fallout from the COVID-19 pandemic, user-fee negotiations and potential legislative action are among the device regulatory areas two attorneys from the law firm Paul Hastings expect to be paying...
FDA Updates Labeling Requirement In Emergency Blood Clot Detection Device Guidance
Source : Medtech Insight
The US Food and Drug Administration has updated an emergency guidance published two weeks ago waiving premarket notification requirements for coagulation systems. The
Mark Cuban ‘Very Involved’,” Insists Generics Company CEO
Source : 'Generics Bulletin'
As US billionaire Mark Cuban’s new generics venture takes off, the Mark Cuban Cost Plus Drug Company’s CEO, Alex Oshmyansky talks exclusively to Generics Bulletin about the motivation and purpose...
